申联生物: 申联生物医药（上海）股份有限公司2025年第二次临时股东大会会议资料

Core Viewpoint - The company is holding its second extraordinary general meeting of shareholders in 2025 to discuss significant governance changes, including the cancellation of the supervisory board and amendments to the company's articles of association [1][5][7]. Meeting Procedures - The meeting will confirm the identity of attendees and ensure that only registered shareholders or their proxies can participate in voting [2][3]. - The agenda includes the announcement of the number of shareholders present and their voting rights, followed by the reading of meeting guidelines and the election of vote counters [5]. - Shareholders have the right to speak, inquire, and vote, but must register in advance and adhere to time limits during discussions [2][3][5]. Agenda Items - Proposal 1: The company proposes to cancel the supervisory board and amend the articles of association accordingly, transferring the supervisory functions to the audit committee of the board [6][7]. - Proposal 2: The company aims to revise and establish other operational regulations to align with the updated articles of association and improve governance [7][8]. Voting Process - Voting will be conducted through both on-site and online methods, with specific time frames for participation [4][5]. - The results of the votes will be announced after a break for counting, followed by the reading of the legal opinion by the witnessing lawyer [5][6].